Viewing Study NCT01592292


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-26 @ 1:17 AM
Study NCT ID: NCT01592292
Status: COMPLETED
Last Update Posted: 2016-08-22
First Post: 2012-04-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-11
Start Date Type: None
Primary Completion Date: 2014-12
Primary Completion Date Type: ACTUAL
Completion Date: 2014-12
Completion Date Type: ACTUAL
First Submit Date: 2012-04-11
First Submit QC Date: None
Study First Post Date: 2012-05-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-05-03
Results First Submit QC Date: None
Results First Post Date: 2016-08-22
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-07-06
Last Update Post Date: 2016-08-22
Last Update Post Date Type: ESTIMATED